JCX-8-23 (May 09, 2023)
Present Law And Economic Background Relating To Pharmaceutical Manufacturers And U.S. International Tax Policy
The Senate Committee on Finance has scheduled a public hearing on May 11, 2023, titled “Cross-border Rx: Pharmaceutical Manufacturers and U.S. International Tax Policy.” The staff of the Joint Committee on Taxation has prepared a document that describes legal and economic background on U.S. taxation of U.S. multinational corporations and their cross-border activities.
The Senate Committee on Finance has scheduled a public hearing on May 11, 2023, titled “Cross-border Rx: Pharmaceutical Manufacturers and U.S. International Tax Policy.” The staff of the Joint Committee on Taxation has prepared a document that describes legal and economic background on U.S. taxation of U.S. multinational corporations and their cross-border activities.
Related Publications
-
JCX-43-24 (September 10, 2024)
Description Of The Chairman's Amendment In The Nature Of A Substitute To H.R. 3269, The “Law Enforcement Innovate To De-Escalate Act”
view details -
JCX-38-24 (September 09, 2024)
Description Of H.R. 3269, The “Law Enforcement Innovate To De-Escalate Act”
view details -
JCX-36-24 (July 26, 2024)
Tax Incentives For Economic Development And Financing
view details